Investor FAQs

Investor FAQs

Show All
Where is Blueprint headquartered?
The Company’s headquarters are located at 45 Sidney Street, Cambridge, MA, 02139. The main office number is 617 374 7580.
On which stock exchange are Blueprint shares traded, what is the ticker symbol and when did it go public?
Blueprint’s stock is traded on the NASDAQ Global Market under the symbol BPMC. Their initial public offering was on April 30, 2015.
What is Blueprint’s CUSIP number?
The CUSIP number for the Company’s common stock is 09627Y 109.
How can I purchase Blueprint common stock?
Shares of Blueprint’s common stock can be purchased by contacting a securities broker of your choice. Blueprint does not have a direct stock purchase plan.
Does Blueprint have a dividend reinvestment program?
Blueprint does not currently offer a dividend reinvestment program and does not expect to declare or pay dividends on our common stock in the foreseeable future.
Who is Blueprint’s transfer agent?
Our transfer agent is:
Computershare Trust Company, N.A.
P.O. Box 43010
Providence, RI 02940
888 909 9922
When is Blueprint’s fiscal year-end?
The Company’s fiscal year ends on December 31.
Who are Blueprint’s outside legal counsel and independent auditors?
Our outside legal counsel is:
Goodwin Proctor, LLP
53 State Street
Boston, MA 02109
617 570 1000

Our independent auditor is:
Ernst & Young
200 Clarendon Street
Boston, MA 02116
617 266 2000
Where can I find Blueprint’s SEC filings? Where can I download and view quarterly and annual reports?
Quarterly and annual reports, as well as other SEC filings, can be accessed on the SEC Filings section of our Investor Relations webpage or directly from the SEC at www.sec.gov.
Whom should I contact if I have future questions?
You can submit questions to Blueprint’s investor relations department by contacting ir@blueprintmedicines.com.